Piramal lines up $40M investment in equipment and technology

Piramal Pharma Solutions is taking steps to avoid some of the pitfalls its neighbors have encountered. The Indian contract manufacturer is lining up a $40 million investment to ensure its facilities have the equipment and technologies to keep clients and regulators happy. Some of the new equipment is already in place. Piramal touted its new advanced flow reactor systems and antibody-drug conjugate technology. Article | More

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.